To ask the Secretary of State for Health and Social Care, what (a) representations his Department has received on the work of the UK Antimicrobial Resistance (AMR) Diagnostics Collaborative and (b) discussions have taken place between his Department and members of that group; what the timetable is for the publication of the AMR Diagnostics Collaborative's report; and (c) if he will make a statement.
Over the last five years, implementation of the United Kingdom antimicrobial resistance (AMR) strategy has been overseen and driven by a cross-Government High Level Steering Group, chaired by the Chief Medical Officer for England.
Professor Dame Sue Hill, Chief Scientific Officer for NHS England, leads work to deliver the Government’s ambitions for diagnostics as part of the strategy. NHS England established the UK AMR Diagnostics Collaborative to support delivery of the United Kingdom’s diagnostics ambitions for AMR. The Collaborative has played a valuable role in developing the diagnostics elements of the new UK five-year national action plan on AMR, published in January this year.
The Department continues to work closely with the UK AMR Diagnostics Collaborative, which currently has no plans to publish a report.